Infertility

 
IBSA Educational Symposium
  Increasing success rate in IVF through improved clinical and laboratory procedures

 

08:30-10:00
IMPROVING THE RESULTS OF ART (I)
Chairpersons

Zhou Canquan, China
Dominique de Ziegler, France
Jie Qiao, China
Capsule
Improving the results of ART requires meticulous analysis and an understanding of failures
 08:30-08:50
Total quality in IVF: Personalized training in critical IVF steps
Amelia Rodriguez, Spain
 08:50-09:15
Error free ART
Rita Vassena, Spain
 09:15-09:35
Recurrent implantation failures
Tin Chiu Li, Hong Kong
 09:35-10:00
Surgical or medical treatment of fibroids?
Jacques Donnez, Belgium
10:00-10:20
Coffee break

 

 10:20-11:50
 IMPROVING THE RESULTS OF ART (2)
Chairpersons

 Amelia Rodriguez , Spain
 Marie-Madeleine Dolmans, Belgium
 Tin Chiu Li, Hong Kong

 10:20-10:40
 Dealing with ART failure: What to offer next?
 Dominique de Ziegler , France
 10:40-11:05
 How to improve ovarian responses to COS
 Norbert Gleicher, USA

 11:05-11:25
 Can acupuncture improve clinical pregnancy in IVF?
 Jie Qiao , China

 11:25-11:50
 The donor egg model: Analyzing ovarian responses to COS in oocyte donors
 Amelia Rodriguez , Spain

 11:50-12:40

  Lunch break
 12:40-14:10
 IMPROVED IMPLANTATION AND LUTEAL SUPPORT
 Supported by Besins Healthcare
Capsule
 Endometrial preparation and support is a cornerstone in IVF and egg donation programs

Chairpersons
 Norbert Gleicher, USA
 Zion Ben Rafael, Israel 

 12:40-13:00
 Implantation window
 Barbara Wirleitner, Nicolas Zech, Austria

 13:00-13:25
 Endometrial preparation with estrogen
 Philippe Bouchard, France
 13:25-13:45
 Ideal route of progesterone administration for luteal phase support
 Salim Daya, Canada

 13:45-14:10
 Thyroid and fertility
 Philippe Bouchard, France

 14:10-14:30

  Poster viewing

  

 14:30-16:00
FERTILITY PRESERVATION IN CANCER PATIENTS
Capsule
ASRM ethics committee: “Cancer patients should be informed of options for fertility preservation and future reproduction prior to cancer treatment. Reproduction in the context of cancer raises a number of ethical issues related to both patient and offspring welfare.” Where are we and where are we heading?
Chairpersons
Rita Vassena, Spain
Norbert Gleicher, USA
 14:30-14:50
Fertility preservation in cancer patients
Jacques Donnez, Belgium
 14:50-15:15
Risk of malignant cells in the ovarian transplant: A place for the artificial ovary
Marie-Madeleine Dolmans , Belgium
 15:15-15:40
Ovarian tissue transplantation
Jacques Donnez, Belgium
 15:40-16:00
The future of fertility preservation
Marie-Madeleine Dolmans, Belgium
 16:00-16:30
  Coffee break

 

 16:30-18:00
SOCIAL FREEZING: GOOD NEWS OR BAD NEWS FOR WOMEN?
Capsule 
 It seems that social freezing is not synchronized with the need for it.  While social freezing is better before age 35, women in that age group have different factors to consider when deciding whether to actually freeze, since they may still hope to conceive spontaneously or with treatment. Is it a good solution for the wrong age group?
Chairpersons
Norbert Gleicher, USA
Tin Chiu Li, Hong Kong
 16:30-17:00
Social freezing: Who, when, and why?
Rita Vassena, Spain
 17:00-17:30
Social freezing of eggs and ovaries: Possibilities and ethics
Marie-Madeleine Dolmans, Belgium
 17:30-18:00 Social freezing: Reality or a dream?
Gab Kovacs, Australia

  

 08:30-10:00
 OVULATION INDUCTION
Capsule
There are enough proofs to show that low dose stimulation results in similar or better results in IVF, so why, despite the risks involved with higher doses,is low dose not implemented across the board?
Chairpersons
Amelia Rodriguez, Spain
Salim Daya, Canada
 08:30-09:15
Debate: Is low intensity stimulation always "better" stimulation?
Yes: Amelia Rodriguez , Spain
 No: Nicholas Zech , Austria
 Discussion
 09:15-09:35
HCG vs. GnRHa for ovulation trigger
Salim Daya, Canada
 09:35-10:00
Is ovarian aging slower in PCOS patients?
Zion Ben Rafael , Israel 
 10:00-10:20  Coffee break

  

 10:20-11:50
 OVARIAN RESPONSE/RESERVE MARKERS
Capsule
Ovarian response to stimulation is the ultimate reserve test.  Therefore, can we do without the ovarian reserve markers in low responders?
Chairpersons Seang Lin Tan, Canada
 10:20-10:40
Role of ovarian response markers in assisted reproduction
Ernest Ng, Hong Kong
 10:40-11:25
Debate: Can AMH predict pregnancy rates better than other markers?
Yes: Kate McIlwaine, Australia
No: Nicolas Zech, Austria
Discussion
 11:25-11:50
Biomarkers for endometrial receptivity are superior to genetic tests for implantation
Tracey Edgell, Australia
 11:50-12:40
 Lunch break

  

 12:40-14:10
OPERATIVE PROCEDURES TO IMPROVE IMPLANTATION

 Capsule
Different surgical procedures are believed to improve implantation and results of treatment. What are the evidences?
Chairpersons
Amelia Rodriguez, Spain 
Ernest Ng, Hong Kong
 12:40-13:00
Bias in the management of hydrosalpinges
Tin Chiu Li, Hong Kong
 13:00-13:25
Should fibroids be operated on before IVF?  What are the evidences?
Zion Ben Rafael, Israel
 13:25-14:10
Debate:
Proposition: Endometrial scratch can improve implantation
Tin Chiu Li, Hong Kong
Opposition: No proofs that endometrial scratch can improve implantation 
Nicolas Zech, Austria
Discussion 
 14:10-14:30  Poster Viewing

  

 
Workshop from Time-lapse to PGS: Can we improve embryo culture and selection?
Sessions 9-10
Capsule
Research on markers for embryo selection has come full circle to morphology.  Combined with time-lapse technology, the gaps between the limited examination performed in the IVF laboratory and the dynamic nature of embryonic growth have been closed. Continuous monitoring offers information on events like timing of cell division, fragmentation, multi-nucleation, compaction, blastulation, and more. Time-lapse technology also offers a list of secondary advantages including flexible gas mixture, grouping of embryos, monitoring, archiving, etc. Is the technology now proving to provide better results?

  

 14:30-16:00
 DOES TIME-LAPSE PROVIDE BETTER RESULTS?
Chairpersons
 Norbert Gleicher, USA
Salim Daya, Canada
 14:30-15:30
Debate: If you are not using time-lapse as part of your culture system, your patients are at a disadvantage 
Not True: Nicolas Zech, Austria
True: Rita Vassena, Spain
Discussion 

 15:30-16:00
Can we pharmacologically affect embryo ploidy?
Norbert Gleicher, USA

 16:00-16:30

  Coffee break

  

 16:30-18:00
PGS/PGD

 Chairpersons
Gab Kovacs, Australia
Seang Lin Tan, Canada
 16:30-17:15
Debate: To maximize the outcome of IVF treatment every embryo should undergo PGS
Yes: Gab Kovacs, Australia
No: Norbert Gleicher, USA
Discussion
 17:15-17:35
 Pre-implantation Genetic Diagnosis (PGD) in China
Jie Qiao, China
 17:35-18:00
Does CGH array improve IVF outcome?
Rita Vassena, Spain

  

08:30-10:00
RTD with panelists and audience
Moderator
Zion Ben Rafael, Israel
 
Panelists
Norbert Gleicher, USA
Salim Daya, Canada
Jie Qiao, China
Amelia Rodriguez , Spain
Ernst Ng, Hong Kong
 

 Questions to the panel:  
 1. Is androgen supplementation beneficial for women with low functional ovarian reserve?
2. Endometrioma or IVF: What comes first?
3. Septum or IVF: What comes first?
4. Is it still worthwhile treating women with their own eggs after age 42?
5. Stimulation in extreme cases: Low responders
6. Stimulation in extreme cases: PCOS
7. OHSS management
8. Increased progesterone in the follicular phase and outcome of IVF
9. When to transfer a frozen day 7 embryo
10. Are RCTs the only way to establish valuable clinical evidence?
 10:00-10:20

 Coffee break

  

10:20-11:50
PREPARATION FOR IVF
Capsule
Certain issues in pre-IVF preparation remain controversial
Chairpersons
Norbert Gleicher , USA
Mark Brincat, Malta
 10:20-10:40
There is no place for IUI
Ben W.J. Mol, Australia
 10:40-11:05
IVM as replacement first line therapy instead of IUI
Seang Lin Tan, Canada
 11:05-11:25 Endometriosis: Surgery or ART?
Salim Daya, Canada
 11:25-11:50 The role of vitamin D in female reproduction
Mark Brincat, Malta